Royal Bank of Canada’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.6M | Buy |
264,263
+117,859
| +81% | +$12.8M | 0.01% | 1134 |
|
|
2026
Q1 | $13.5M | Buy |
146,404
+3,962
| +3% | +$398K | ﹤0.01% | 1711 |
|
|
2025
Q4 | $14.5M | Sell |
142,442
-430,349
| -75% | -$38.5M | ﹤0.01% | 1703 |
|
|
2025
Q3 | $35.8M | Sell |
572,791
-320,620
| -36% | -$17.4M | 0.01% | 1213 |
|
|
2025
Q2 | $46.5M | Buy |
893,411
+744,663
| +501% | +$33.3M | 0.01% | 975 |
|
|
2025
Q1 | $6.34M | Buy |
148,748
+29,829
| +25% | +$1.29M | ﹤0.01% | 2087 |
|
|
2024
Q4 | $3.63M | Sell |
118,919
-15,351
| -11% | -$432K | ﹤0.01% | 2575 |
|
|
2024
Q3 | $3.08M | Sell |
134,270
-25,331
| -16% | -$717K | ﹤0.01% | 2667 |
|
|
2024
Q2 | $4.61M | Buy |
159,601
+17,953
| +13% | +$418K | ﹤0.01% | 2255 |
|
|
2024
Q1 | $2.92M | Sell |
141,648
-110,483
| -44% | -$2.37M | ﹤0.01% | 2615 |
|
|
2023
Q4 | $6.82M | Sell |
252,131
-28,227
| -10% | -$740K | ﹤0.01% | 2015 |
|
|
2023
Q3 | $8.31M | Buy |
280,358
+31,332
| +13% | +$1.1M | ﹤0.01% | 1711 |
|
|
2023
Q2 | $8.91M | Buy |
249,026
+13,435
| +6% | +$386K | ﹤0.01% | 1669 |
|
|
2023
Q1 | $5.52M | Sell |
235,591
-1,049
| -0.4% | -$30K | ﹤0.01% | 2003 |
|
|
2022
Q4 | $6.44M | Sell |
236,640
-13,262
| -5% | -$607K | ﹤0.01% | 1941 |
|
|
2022
Q3 | $13.5M | Buy |
249,902
+13,340
| +6% | +$685K | ﹤0.01% | 1335 |
|
|
2022
Q2 | $9.54M | Sell |
236,562
-24,313
| -9% | -$1.2M | ﹤0.01% | 1596 |
|
|
2022
Q1 | $17.3M | Sell |
260,875
-23,672
| -8% | -$1.62M | ﹤0.01% | 1322 |
|
|
2021
Q4 | $28.5M | Sell |
284,547
-22,860
| -7% | -$2.36M | 0.01% | 1155 |
|
|
2021
Q3 | $38.4M | Sell |
307,407
-18,426
| -6% | -$2.19M | 0.01% | 893 |
|
|
2021
Q2 | $40.5M | Buy |
325,833
+37,166
| +13% | +$5M | 0.01% | 869 |
|
|
2021
Q1 | $44.1M | Sell |
288,667
-28,111
| -9% | -$4.25M | 0.01% | 764 |
|
|
2020
Q4 | $40.8M | Buy |
316,778
+222,374
| +236% | +$25.6M | 0.01% | 798 |
|
|
2020
Q3 | $10.6M | Sell |
94,404
-587
| -0.6% | -$53.7K | ﹤0.01% | 1507 |
|
|
2020
Q2 | $7.71M | Sell |
94,991
-17,009
| -15% | -$1.37M | ﹤0.01% | 1666 |
|
|
2020
Q1 | $7.79M | Buy |
112,000
+97,774
| +687% | +$7.5M | ﹤0.01% | 1513 |
|
|
2019
Q4 | $1.11M | Buy |
14,226
+11,900
| +512% | +$858K | ﹤0.01% | 3368 |
|
|
2019
Q3 | $149K | Sell |
2,326
-6,235
| -73% | -$549K | ﹤0.01% | 4613 |
|
|
2019
Q2 | $739K | Buy |
8,561
+2,498
| +41% | +$191K | ﹤0.01% | 3564 |
|
|
2019
Q1 | $465K | Sell |
6,063
-3,597
| -37% | -$199K | ﹤0.01% | 3772 |
|
|
2018
Q4 | $363K | Buy |
+9,660
| New | +$356K | ﹤0.01% | 3940 |
|
Other funds holding GH
DTC
Royal Bank of Canada's GH Position: Q2 2026 in Review
Royal Bank of Canada increased its Guardant Health (GH) stake by 81% in Q2 2026, buying an estimated $12.8M and bringing the position to 264,263 shares worth $39.6M. The position accounts for 0.01% of the portfolio, ranked #1134.
Royal Bank of Canada first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $46.5M in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Royal Bank of Canada held 264,263 shares of Guardant Health worth $39.6M as of Q2 2026.
- Royal Bank of Canada bought 117,859 Guardant Health shares in Q2 2026, an estimated $12.8M.
- Guardant Health made up 0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #1134 holding.
- Royal Bank of Canada first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- Royal Bank of Canada's Guardant Health position peaked at $46.5M in Q2 2025.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.